DSE:BXPHARMA Market Cap

DSE:BXPHARMA has a market cap or net worth of 51.26 billion as of March 9, 2026. Its market cap has increased by 50.59% in one year.

Market Cap

51.26B

Enterprise Value

58.55B

Revenue

46.34B

Ranking

n/a

PE Ratio

8.07

Stock Price

114.90

Market Cap Chart

Since January 3, 2000, DSE:BXPHARMA's market cap has increased from 1.91B to 51.26B, an increase of 2,582.40%. That is a compound annual growth rate of 13.38%.

Market Cap History

Date	Market Cap	% Change
Mar 9, 2026	51.26B	12.54%
Dec 30, 2025	45.55B	25.12%
Dec 30, 2024	36.40B	-44.19%
Dec 28, 2023	65.22B	-
Dec 29, 2022	65.22B	-24.13%
Dec 30, 2021	85.97B	1.15%
Dec 30, 2020	Pro	Pro
Dec 30, 2019	Pro	Pro
Dec 27, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Renata	49.23B
Unilever Consumer Care	41.50B
Beacon Pharmaceuticals	23.56B
The ACME Laboratories	16.48B
Square Pharmaceuticals PLC.	190.14B
The IBN SINA Pharmaceutical Industry	9.96B
Asiatic Laboratories	7.75B
Orion Pharma	7.00B

Market Cap Rankings